Publications

The Thromboxane Receptor Antagonist Ntp42 Promotes Beneficial Adaptation and Preserves Cardiac Function in Experimental Models of Right Heart Overload

AuthID
P-00X-PXJ

Author(s)

Mulvaney, EP

Renzo, F

Adao, R

Dupre, E

Bialesova, L

Salvatore, V

Reid, HM

Conceicao, G

Grynblat, J

Llucia-Valldeperas, A

Michel, JB

Bras-Silva, C

Laurent, CE

Howard, LS

Montani, D

Humbert, M

Noordegraaf, AV

Perros, F

Mendes-Ferreira, P

Kinsella, BT

Document Type

Article

Year published

2022

Published

in FRONTIERS IN CARDIOVASCULAR MEDICINE, ISSN: 2297-055X

Volume: 9

Indexing

Wos^®

Scopus^®

Crossref^®5

Pubmed^®

Unpaywall^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.3389/fcvm.2022.1063967

Pubmed: 36588576

SCOPUS: 2-s2.0-85145050535

Unpaywall: 10.3389/fcvm.2022.1063967

Wos: WOS:000903806600001

Source Identifiers

ISSN: 2297-055X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

The Thromboxane Receptor Antagonist Ntp42 Promotes Beneficial Adaptation and Preserves Cardiac Function in Experimental Models of Right Heart Overload

Useful Links

Get Help

Federated Authentication (Click on the image)

The Thromboxane Receptor Antagonist Ntp42 Promotes Beneficial Adaptation and Preserves Cardiac Function in Experimental Models of Right Heart Overload

Useful Links

Get Help